Before treatment, the CSFs IgG, IgM, and IgA of patients in the TBM group were higher than those in the healthy population (29) and lower than the corresponding values of patients with multiple sclerosis (30) and neurosyphilis (31). This evidence concerns the gene CD79A and neurosyphilis.